Know who won and who lost, within two days of each rule.

Medicare's inpatient rule decides which new drugs and devices earn an add-on payment. It is proposed each April and final each August. Within two business days of each, subscribers get one email: which public companies gained a payment, which kept one, and which lost one.

What you get

• Every public company affected, by ticker
• Losses first, because nobody announces them
• Maximum add-on payment and implied cost per case for each technology
• The source rule and file, cited

Coming next: the outpatient rule and its pass-through payments, each July and November.

Sample alert

Built from the FY 2027 inpatient final rule. This is what a subscriber would have received.